API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
66
PharmaCompass offers a list of Teriparatide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Teriparatide manufacturer or Teriparatide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Teriparatide manufacturer or Teriparatide supplier.
PharmaCompass also assists you with knowing the Teriparatide API Price utilized in the formulation of products. Teriparatide API Price is not always fixed or binding as the Teriparatide Price is obtained through a variety of data sources. The Teriparatide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (1-34)-Human parathyroid hormone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (1-34)-Human parathyroid hormone, including repackagers and relabelers. The FDA regulates (1-34)-Human parathyroid hormone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (1-34)-Human parathyroid hormone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (1-34)-Human parathyroid hormone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (1-34)-Human parathyroid hormone supplier is an individual or a company that provides (1-34)-Human parathyroid hormone active pharmaceutical ingredient (API) or (1-34)-Human parathyroid hormone finished formulations upon request. The (1-34)-Human parathyroid hormone suppliers may include (1-34)-Human parathyroid hormone API manufacturers, exporters, distributors and traders.
click here to find a list of (1-34)-Human parathyroid hormone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A (1-34)-Human parathyroid hormone DMF (Drug Master File) is a document detailing the whole manufacturing process of (1-34)-Human parathyroid hormone active pharmaceutical ingredient (API) in detail. Different forms of (1-34)-Human parathyroid hormone DMFs exist exist since differing nations have different regulations, such as (1-34)-Human parathyroid hormone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A (1-34)-Human parathyroid hormone DMF submitted to regulatory agencies in the US is known as a USDMF. (1-34)-Human parathyroid hormone USDMF includes data on (1-34)-Human parathyroid hormone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The (1-34)-Human parathyroid hormone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of (1-34)-Human parathyroid hormone suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing (1-34)-Human parathyroid hormone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for (1-34)-Human parathyroid hormone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture (1-34)-Human parathyroid hormone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain (1-34)-Human parathyroid hormone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a (1-34)-Human parathyroid hormone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of (1-34)-Human parathyroid hormone suppliers with NDC on PharmaCompass.
(1-34)-Human parathyroid hormone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of (1-34)-Human parathyroid hormone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right (1-34)-Human parathyroid hormone GMP manufacturer or (1-34)-Human parathyroid hormone GMP API supplier for your needs.
A (1-34)-Human parathyroid hormone CoA (Certificate of Analysis) is a formal document that attests to (1-34)-Human parathyroid hormone's compliance with (1-34)-Human parathyroid hormone specifications and serves as a tool for batch-level quality control.
(1-34)-Human parathyroid hormone CoA mostly includes findings from lab analyses of a specific batch. For each (1-34)-Human parathyroid hormone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
(1-34)-Human parathyroid hormone may be tested according to a variety of international standards, such as European Pharmacopoeia ((1-34)-Human parathyroid hormone EP), (1-34)-Human parathyroid hormone JP (Japanese Pharmacopeia) and the US Pharmacopoeia ((1-34)-Human parathyroid hormone USP).